FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897590587> ?p ?o ?g. }

• W2897590587 endingPage "6679" @default.
• W2897590587 startingPage "6666" @default.
• W2897590587 abstract ": Cancer cells in quiescence (G0 phase) are resistant to death, and re-entry of quiescent cancer cells into the cell-cycle plays an important role in cancer recurrence. Here we show that two p53-responsive miRNAs utilize distinct but complementary mechanisms to promote cancer cell quiescence by facilitating stabilization of p27. Purified quiescent B16 mouse melanoma cells expressed higher levels of miRNA-27b-3p and miRNA-455-3p relative to their proliferating counterparts. Induction of quiescence resulted in increased levels of these miRNAs in diverse types of human cancer cell lines. Inhibition of miRNA-27b-3p or miRNA-455-3p reduced, whereas its overexpression increased, the proportion of quiescent cells in the population, indicating that these miRNAs promote cancer cell quiescence. Accordingly, cancer xenografts bearing miRNA-27b-3p or miRNA-455-3p mimics were retarded in growth. miRNA-27b-3p targeted cyclin-dependent kinase regulatory subunit 1 (CKS1B), leading to reduction in p27 polyubiquitination mediated by S-phase kinase-associated protein 2 (Skp2). miRNA-455-3p targeted CDK2-associated cullin domain 1 (CAC1), which enhanced CDK2-mediated phosphorylation of p27 necessary for its polyubiquitination. Of note, the gene encoding miRNA-27b-3p was embedded in the intron of the chromosome 9 open reading frame 3 gene that was transcriptionally activated by p53. Similarly, the host gene of miRNA-455-3p, collagen alpha-1 (XXVII) chain, was also a p53 transcriptional target. Collectively, our results identify miRNA-27b-3p and miRNA-455-3p as important regulators of cancer cell quiescence in response to p53 and suggest that manipulating miRNA-27b-3p and miRNA-455-3p may constitute novel therapeutic avenues for improving outcomes of cancer treatment. SIGNIFICANCE: Two novel p53-responsive microRNAs whose distinct mechanisms of action both stabilize p27 to promote cell quiescence and may serve as therapeutic avenues for improving outcomes of cancer treatment." @default.
• W2897590587 created "2018-10-26" @default.
• W2897590587 creator A5003787100 @default.
• W2897590587 creator A5004195195 @default.
• W2897590587 creator A5020462973 @default.
• W2897590587 creator A5036126584 @default.
• W2897590587 creator A5039604144 @default.
• W2897590587 creator A5045130561 @default.
• W2897590587 creator A5047510477 @default.
• W2897590587 creator A5048927086 @default.
• W2897590587 creator A5072813429 @default.
• W2897590587 creator A5072900322 @default.
• W2897590587 creator A5073896710 @default.
• W2897590587 creator A5075001397 @default.
• W2897590587 creator A5085722199 @default.
• W2897590587 creator A5086785352 @default.
• W2897590587 date "2018-12-01" @default.
• W2897590587 modified "2023-10-13" @default.
• W2897590587 title "A p53-Responsive miRNA Network Promotes Cancer Cell Quiescence" @default.
• W2897590587 cites W1573825647 @default.
• W2897590587 cites W1686076540 @default.
• W2897590587 cites W1761753578 @default.
• W2897590587 cites W1974208182 @default.
• W2897590587 cites W1980101293 @default.
• W2897590587 cites W1991793875 @default.
• W2897590587 cites W1993497779 @default.
• W2897590587 cites W1998625763 @default.
• W2897590587 cites W2004838336 @default.
• W2897590587 cites W2006875030 @default.
• W2897590587 cites W2010889684 @default.
• W2897590587 cites W2013721931 @default.
• W2897590587 cites W2021491682 @default.
• W2897590587 cites W2026004604 @default.
• W2897590587 cites W2027097496 @default.
• W2897590587 cites W2029910909 @default.
• W2897590587 cites W2039252915 @default.
• W2897590587 cites W2048965284 @default.
• W2897590587 cites W2060683430 @default.
• W2897590587 cites W2070291618 @default.
• W2897590587 cites W2073996456 @default.
• W2897590587 cites W2074106315 @default.
• W2897590587 cites W2084136291 @default.
• W2897590587 cites W2091015937 @default.
• W2897590587 cites W2092090368 @default.
• W2897590587 cites W2104014368 @default.
• W2897590587 cites W2117365291 @default.
• W2897590587 cites W2149047387 @default.
• W2897590587 cites W2149511654 @default.
• W2897590587 cites W2157754963 @default.
• W2897590587 cites W2163931326 @default.
• W2897590587 cites W2253938130 @default.
• W2897590587 cites W2412592840 @default.
• W2897590587 cites W2530415702 @default.
• W2897590587 cites W2603712266 @default.
• W2897590587 cites W2757490447 @default.
• W2897590587 cites W2760081946 @default.
• W2897590587 cites W2786169642 @default.
• W2897590587 cites W2801036911 @default.
• W2897590587 cites W4256350677 @default.
• W2897590587 doi "https://doi.org/10.1158/0008-5472.can-18-1886" @default.
• W2897590587 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30301840" @default.
• W2897590587 hasPublicationYear "2018" @default.
• W2897590587 type Work @default.
• W2897590587 sameAs 2897590587 @default.
• W2897590587 citedByCount "23" @default.
• W2897590587 countsByYear W28975905872019 @default.
• W2897590587 countsByYear W28975905872020 @default.
• W2897590587 countsByYear W28975905872021 @default.
• W2897590587 countsByYear W28975905872022 @default.
• W2897590587 countsByYear W28975905872023 @default.
• W2897590587 crossrefType "journal-article" @default.
• W2897590587 hasAuthorship W2897590587A5003787100 @default.
• W2897590587 hasAuthorship W2897590587A5004195195 @default.
• W2897590587 hasAuthorship W2897590587A5020462973 @default.
• W2897590587 hasAuthorship W2897590587A5036126584 @default.
• W2897590587 hasAuthorship W2897590587A5039604144 @default.
• W2897590587 hasAuthorship W2897590587A5045130561 @default.
• W2897590587 hasAuthorship W2897590587A5047510477 @default.
• W2897590587 hasAuthorship W2897590587A5048927086 @default.
• W2897590587 hasAuthorship W2897590587A5072813429 @default.
• W2897590587 hasAuthorship W2897590587A5072900322 @default.
• W2897590587 hasAuthorship W2897590587A5073896710 @default.
• W2897590587 hasAuthorship W2897590587A5075001397 @default.
• W2897590587 hasAuthorship W2897590587A5085722199 @default.
• W2897590587 hasAuthorship W2897590587A5086785352 @default.
• W2897590587 hasBestOaLocation W28975905871 @default.
• W2897590587 hasConcept C104317684 @default.
• W2897590587 hasConcept C121608353 @default.
• W2897590587 hasConcept C145059251 @default.
• W2897590587 hasConcept C153911025 @default.
• W2897590587 hasConcept C29537977 @default.
• W2897590587 hasConcept C502942594 @default.
• W2897590587 hasConcept C54355233 @default.
• W2897590587 hasConcept C62112901 @default.
• W2897590587 hasConcept C86803240 @default.
• W2897590587 hasConcept C95444343 @default.
• W2897590587 hasConcept C96232424 @default.
• W2897590587 hasConceptScore W2897590587C104317684 @default.

• next